"Based in the Valencia Commerce Center, MannKind is planning to start a Phase II study of a product for patients with advanced melanoma, and Phase I clinical trials of a product to treat tumors, metastatic and refractory diseases. It also conducts preclinical studies of drug candidates intended to treat certain other cancers, inflammatory diseases and obesity."

These trials are still on hold until FDA approval of Afrezza,Right?

http://scvnews.com/?p=26635